There is still time to register to attend this exciting upcoming ''QM in Pharma'' 1-day meeting in London next month ! Event organised by Exscientia and Molecular Graphics and Modelling Society
=== QM in Pharma ==
SOAS, London, September 18th 2024
==Synopsis
Quantum Mechanics (QM) has established itself as a key tool in the pharmaceutical industry in areas such as elucidation of drug-target interactions, estimation of ligand binding affinities, descriptor calculation for QSPR/QSAR modelling and the prediction of molecular spectroscopic properties.
The QM in Pharma meeting aims to highlight some of the key developments of quantum mechanics applied in the pharmaceutical industry and stimulate discussion about the future direction of new and emerging methodologies.
We invite speakers to share their research focused on the following themes:
– Quantum Mechanics or QM/MM approaches toward drug-target affinity or drug property prediction
– Quantum Mechanics/Machine Learning models and their application to drug discovery problems
– Quantum computing applications to drug discovery problems
== Confirmed speakers
Fred Manby, Iambic Therapeutics, US
David Pearlman, QSimulate, US
Justin S. Smith , NVIDIA, US
Jack Glancy, GSK, UK
Georg Schusteritsch, Kuano, UK
Christoph Riplinger, FACCTs, DE
Beth Caine, Exscientia, UK
== Conference website
https://lnkd.in/ezJYMiGy
#CADD #drugdiscovery #compchem #QM #machinelearning
Scientific Program Manager, EMEA, NVIDIA
1moBravo à toute l équipe 👏🏻👏🏻👏🏻 tjs aussi admirative du dynamisme de Qubit Pharmaceuticals et de la diversité des informatiques scientifiques que vous couvrez. Tout simplement 🙌. Jean-Philip Piquemal Robert Marino très belle intervention Robert.